Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 8Liver Neoplasms 5Carcinoma, Hepatocellular 4Lung Neoplasms 3Squamous Intraepithelial Lesions 2Prostatic Neoplasms 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Unresectable Pancreatic Cancer 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Rectal Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Neoplasm Metastasis 1Melanoma 1Lymphatic Metastasis 1Liver, Cancer of, Non-Resectable 1Laryngeal Neoplasms 1Hilus Pulmonary Neoplasms 1Head and Neck Neoplasms 1HIV Seropositivity 1Gallbladder Neoplasms 1Extremities Neoplasms 1Esophageal Neoplasms 1Colorectal Liver Metastases 1Carcinoma, Renal Cell 1

Interventions

tislelizumab 1lenvatinib 1Radiomics 1Positron Emission Tomography Computed Tomography 1Pancreaticoduodenectomy 1Electroporation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Pancreatic Ductal Adenocarcinoma × Electroporation × Clear all
NCT03257150 2022-08-11

A Study of the Use of Irreversible Electroporation in Pancreatic Ductal Cancer

University Health Network, Toronto

Phase NA Completed
12 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡